Why I’m BEARISH on this stock that’s soared 300% in just 3 years!

Rupert Hargreaves explains why he’s avoiding this market darling that’s three-bagged in just three years.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The last time I covered premium carbonated mixers group Fevertree (LSE: FEVR), I claimed the stock could be a great investment as its growth showed no signs of losing its fizz.

Nearly a year on, and I’m willing to admit that I made a bad call. Soon after I issued my ‘buy’ advice on the 13th of March, the stock spiked and rose more than 50% between the beginning of March and the beginning of September. However, in the months after, the stock has declined and is currently trading only 8.3% higher than where it was at the time of my recommendation.

This is a sharp slow down from a company that has seen its share price rise more than 300% in just three years. Now, I’m beginning to wonder if this could be the beginning of a more substantial decline.

Slowing growth

Shares in Fevertree have languished even though the company has issued several upbeat trading updates over the past 12 months. The latest update, published at the beginning of 2019, informed investors that full-year revenue for the group is expected to rise 39% year-on-year, thanks to “very strong” revenue growth in the UK and “significant operational progress” in the US.

The problem is, no matter how you look at it, Fevertree’s growth is slowing. Between 2016 and 2017, revenue increased 70%, that’s nearly double the growth rate the company expects to report for 2018.

Analysts are expecting a further slowdown in 2019. They’ve pencilled in revenue growth of just 19%, although the company does have a track record of outperforming City expectations.

Also, I’m shocked that Fevertree’s US revenue is growing so slowly. According to the latest trading update, revenue in this region increased by 21% in 2018. Considering the company only has a small presence in the US, and it’s such a massive market, I wouldn’t have been surprised if the group reported a growth rate of 50%, or more. In the first half of 2018, US revenue was only £15.1m, implying the firm has increased sales by around £6m for the year. 

As some estimates put the size of the total US carbonated drinks market at more than $350bn, Fevertree’s relatively minuscule sales growth doesn’t instil confidence in the brand.

Time to sell?

With growth slowing, I think it’s going to become harder for the company to continue to justify its premium valuation. The stock is currently trading at a forward P/E of 53, falling to 46 if it meets growth forecasts for 2019. This multiple makes it one of the most expensive companies on the London market. If growth slows further, it’s difficult to see how it can continue to sustain the premium rating.

Even based on current earnings growth, the stock looks expensive. It’s trading at a PEG ratio of 3.5. There’s no evidence of support either. The shares currently support a dividend yield of 0.6%.

All in all, considering Fevertree’s current valuation and the company’s slowing sales growth, I think the shares are due for a re-rating. And the decline could be significant.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Person holding magnifying glass over important document, reading the small print
Investing Articles

Just released: our top 3 small-cap stocks to consider buying in October [PREMIUM PICKS]

Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

Read more »

Investing Articles

How I’d use an empty Stocks and Shares ISA to aim for a £1,000 monthly passive income

Here's how using a Stocks and Shares ISA really could help those of us who plan to invest for an…

Read more »

Investing Articles

This FTSE stock is up 20% and set for its best day ever! Time to buy?

This Fool takes a look at the half-year results from Burberry (LON:BRBY) to see if the struggling FTSE stock might…

Read more »

Investing Articles

This latest FTSE 100 dip could be an unmissable opportunity to pick up cut-price stocks

The FTSE 100 has pulled back with the government’s policy choices creating some negative sentiment. But this gives us a…

Read more »

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

As the WH Smith share price falls 4% on annual results, is it still worth considering?

WH Smith took a hit after this morning’s results left shareholders unimpressed. With the share price down 4%, Mark Hartley…

Read more »

Investing Articles

The Aviva share price just jumped 4.5% but still yields 7.02%! Time to buy?

A positive set of results has put fresh life into the Aviva share price. Harvey Jones says it offers bags…

Read more »

Investing Articles

Can a €500m buyback kickstart the Vodafone share price?

The Vodafone share price has been a loser for investors in recent years, and the dividend has been cut. We…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Growth Shares

3 mistakes I now avoid when choosing which growth stocks to buy

Jon Smith runs through some of the lessons he's learnt the hard way over the years about what to look…

Read more »